Xplico is the market leader in life science valuation, supporting more than 100 biotech and pharma companies across Europe, US and Asia in licensing, partnerships, fundraising, investing, portfolio management and IPOs (Initial Public Offering).As a freelancer, I am responsible for offering to dedicated clients in Biotechs and Life Science industry: . Highly specialized and flexible valuation analysis with unrivaled risk assessment, including: . Multi-scenario evaluation for all parties involved in a deal, . Multi-criteria detailed sensitivity analysis, . Value split for each party along future inflection points.=> 2/3 of new valuations come from existing clients either themselves or through referrals